glp-1 drug market size Agonists Size, Share, Growth Insights 2032 GLP-1 Analogues Market Size, Share

CI, confidence interval

While Zepbound itself is not yet directly linked to this condition, its role in managing diabetes may impact the risk

[DOI] [PMC free article] [PubMed] [Google Scholar] 652.Asmar M., Simonsen L., Arngrim N., Holst J.J., Dela F., Bulow J

Additionally, in a phase 2 trial targeting type 2 diabetes, retatrutide demonstrated significant improvements in glycemic control and substantial weight reduction, maintaining a safety profile comparable to certain approved GLP-1RAs 8 (Supplementary Table S1)

About this article Cite this article Saraiva, J.F.K., Franco, D

Its not hard to understand why sticking with this regime is challenging a large minority of patients report unpleasant side effects such as nausea and vomiting, and some experience additional side effects such as injection-site reactions, infections, heart burn, and headaches